Frontiers in Antibiotics

Original Research

Published on 15 May 2025

Quantification of bactericidal activity using the PATHFAST TB LAM Ag assay during the first 14 days of pulmonary tuberculosis treatment

Ayumi Akinaga
Andreas H. Diacon
Remous Ocloo
Atsushi Yanagida
Naofumi Yoda
Masanori Kawasaki
Yongge Liu

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1574688

509 views

Original Research

Published on 08 May 2025

Vancomycin dosing in neonates: enhancing outcomes using population pharmacokinetics and simulation

Sílvia M. Illamola
Jiraganya (JJ) Bhongsatiern
Angela K. Birnbaum
Shaun S. Kumar
Joshua D. Courter
David B. Haslam
Karel Allegaert
David M. Reith
Pankaj B. Desai
Catherine M. Sherwin

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1568931

601 views

Review

Published on 06 May 2025

Non-antibiotic therapies for multidrug-resistant gastrointestinal infections: an overview of the use of probiotics, natural compounds, and bacteriophages

Manuela Oliveira
Áurea Madureira-Carvalho
Ricardo Jorge Dinis-Oliveira
Diana Dias da Silva

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1554061

542 views

Original Research

Accepted on 05 May 2025

Synergistic Effects of Pandanus fascicularis Extracts and Azithromycin: In-Vitro and In-Silico Antimicrobial Investigation Against MDR Clinical Strains

Mst. Hajera Khatun
Md Rashedul Islam
Shikha Khatun
Amro Ahmed Zalah
Md. Hadisur Rahman Rony
Mst. Munira Khatun
Emad Essa A Wasili Wasili
Jaytirmoy Barmon
Saad Ahmed Sami
Abdulrahman Masmali

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1552382

Perspective

Published on 29 Apr 2025

Data transparency and reproducibility in health research: bridging the gap for early-career researchers

Sanjib Bhakta
Jianping Xie
Federico Pea
Stephen H. Gillespie

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1562002

412 views

Original Research

Published on 28 Apr 2025

Factors influencing the frequency, knowledge, attitudes and practices of antibiotic use in commercial layer chicken farms, Tanzania

Siha Mdemu
Augustine B. Matondo
Jens Peter Christensen
Ahmed E. Amasha
Helena A. Ngowi
Erica Westwood
Sunday O. Ochai
Hezron E. Nonga
Kristina Osbjer
Robinson H. Mdegela

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1571096

711 views

Review

Accepted on 09 Apr 2025

Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials

Andrew DiNardo
Wilber Sabiiti
Stephen Henry Gillespie
Sophia Georghiou
Norbert Heinrich
Norbert Hittel
Sami Taghlabi
Danna Carrero Longlax
Ursula Panzner
Collins Musia

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1570989

204 views

Original Research

Accepted on 07 Apr 2025

The burden, risk factors, and antimicrobial susceptibility pattern associated with Extended Spectrum Beta-Lactamase producing E. coli and K. pneumoniae carriage among neonates and their surroundings at a referral hospital in Moshi municipality

Happiness J Mshana
Dorottya Kovacs
Florida Muro
Katarina Oravcova
Louise Matthews
Blandina Theophil Mmbaga
Ruth Nicolet Zadoks

Frontiers in Antibiotics

doi 10.3389/frabi.2025.1556842

156 views